Ignite Creation Date:
2025-12-24 @ 3:25 PM
Ignite Modification Date:
2026-01-24 @ 9:24 PM
Study NCT ID:
NCT02077192
Status:
COMPLETED
Last Update Posted:
2023-12-11
First Post:
2014-02-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)
Sponsor:
Rigel Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
C-935788-049
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None